¿Cómo se comparó el EPS reciente de THMO con las expectativas?
¿Cómo fue el desempeño de los ingresos de Thermogenesis Holdings Inc THMO en el último trimestre?
¿Cuál es la estimación de ingresos para Thermogenesis Holdings Inc?
¿Cuál es la puntuación de calidad de ganancias de Thermogenesis Holdings Inc?
¿Cuándo informa Thermogenesis Holdings Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Thermogenesis Holdings Inc?
¿Superó Thermogenesis Holdings Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.0001
Precio de apertura
$0.0001
Rango del día
$0.0001 - $0.0001
Rango de 52 semanas
$0.0001 - $0.0007
Volumen
100
Volumen promedio
438
EPS (TTM)
-5.00
Rendimiento de dividendos
--
Cap. de mercado
$1.5K
¿Qué es THMO?
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.